Guided Therapeutics Provides Updates on FDA Application Study Results, 2025 Earnings Increase and Successful Warrant Offering
Guided Therapeutics Inc (GTHP)
NASDAQ:AMEX Investor Relations:
guidedinc.com/investors
Company Research
Source: Business Wire
PEACHTREE CORNERS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless testing platform for cervical cancer detection based on its patented biophotonic technology, provided several updates in conjunction with the Company’s 2025 10k financial report, filed on March 30, 2026.First, preliminary analysis of the FDA clinical study data has been completed. Over 480 women participated in the multicenter trial and there were no adverse events associated with use of LuViva. Of the nearly 100 women determined by independent expert pathology to have significant cervical disease that can lead to cancer, approximately 30% went undetected by the current standard of care consisting of colposcopy followed by biopsy. The primary objective of the study was to show that LuViva could detect a significant number of these “missed” precancers as set forth in the FDA reviewed protocol.According to Mark Faupel, CEO of Guided T
Show less
Read more
Impact Snapshot
Event Time:
GTHP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GTHP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GTHP alerts
High impacting Guided Therapeutics Inc news events
Weekly update
A roundup of the hottest topics
GTHP
Sec Filings
- 3/31/26 - Form 10-K
- 3/12/26 - Form 4
- 3/10/26 - Form 8-K
- GTHP's page on the SEC website